JPRN-UMIN000000813RecruitingPhase 2
Phase II Study of Amrubicin and Nitroglycerin in Third-Line Chemotherapy in Previously Treated Patients with Non-Small-Cell Lung Cancer - Phase II Study of Amrubicin and Nitroglycerin in Third-Line Chemotherapy in Previously Treated Patients with Non-Small-Cell Lung Cancer
Division of Clinical Trial Design and Management, Translational Clinical Center, Kyoto University Hospital0 sites60 target enrollmentStarted: September 12, 2007Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 40years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(a)No treatment with a vasodilator such as calcium channel blockers; (b)No treatment with nitric oxide donationg drugs; (c)No prior chemotherapy using amrubicin; (d)No radiotherapy to evaluable tumor lesions during this protocol treatment (e)Without brain metastasis; (f)No unstable ischemic heart disease; (g)No active hepatitis; (h)No active interstitial pneumonitis; (i)No active hematological disease such as leukemia; (j)No incurable duplicative cancers; (k)No uncontrollable psychological disease; (l)No female under nursing or pregnancy (m)No enrollment in another interventional study
Investigators
Similar Trials
Completed
Phase 1
A Phase I/II Study of Amrubicine and Irinotecan in Patients with Advanced Small Cell Lung Cancersmall cell lung cancerJPRN-C000000150West Japan Oncology Group40
Completed
Phase 2
Phase II study of amrubicin for previously treated advanced non-small cell lung cancerRecurrent non-small cell lung cancerJPRN-UMIN000001751Gunma University Hospital35
Completed
Phase 1
Phase 1-2 Study of Amrubicin plus Nedaplatin for Advanced Non-Small-Cell Lung Canceron-Small-Cell Lung CancerJPRN-UMIN000003282agasaki University Hospital35
Completed
Phase 2
A phase II study of amrubicin for previously treated small cell lung cancerFor patients with recurrent small cell lung cancerJPRN-UMIN000001752Gunma University Hospital35
Unknown
Not Applicable
A phase II study of Amrubicin in patients with previously treated small cell lung cancersmall cell lung cancerJPRN-C000000141Kinki University School of Medicine30